在边缘人格和抑郁症中静脉注射胺
Yara Bachir1, Raymond Kassab1, Caroline Hallal1
1Department of Psychiatry, Hôtel-Dieu de France University Hospital, Beirut, Lebanon.
L'Encephale
|August 22, 2025
概括
在患有多种精神疾病的患者中,静脉胺有效治疗了严重的自杀念头. 这种快速起作用的疗法对抗传统疗法的复杂病例提供了有希望的替代方案.
科学领域:
- 精神病学
- 神经科学
- 药理学
背景情况:
- 严重的自杀念头构成重大临床挑战,特别是在患有并发性精神疾病的患者中.
- 抗治疗重度抑郁症 (MDD) 通常需要探索新的治疗途径.
研究的目的:
- 研究静脉注射胺在治疗活跃自杀念头方面的有效性.
- 评估胺对伴随性疾病的影响,包括主要抑郁症 (MDD),边缘性人格障碍 (BPD),创伤后应激障碍 (PTSD) 和功能神经障碍 (FND).
主要方法:
- 一个病例报告详细介绍了一名24岁的女性患有抗治疗MDD和活跃的自杀念头.
- 提供九次静脉注射胺.
主要成果:
- 自杀念头和抑郁症状显著减少,蒙哥马利- 阿斯伯格抑郁评分表 (MADRS) 的得分从45降至11.
- 在治疗后观察到持续改善的冲动性和易怒性.
结论:
- 即使在复杂的精神病状况下,静脉注射胺也能迅速缓解严重的自杀倾向.
- 胺对谷氨酸通路的作用是一个有前途的治疗策略,在某些情况下可能超过传统治疗方法,如电治疗 (ECT).
- 需要进一步的研究来探索胺在治疗严重的自杀倾向和并发性精神疾病方面的长期有效性和安全性.
相关概念视频
Borderline Personality Disorder
142
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Genetic and Environmental Contributions
Borderline Personality...
142
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Electroconvulsive Therapy
185
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
185
Mania and Antimanic Drugs: Overview
319
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
319
Parenteral Anesthetics: Overview
196
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
196
CNS Depressants: Barbiturates and Benzodiazepines
467
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
467


